Skip to content

SmallCap Round Up: Physiomics, Ergomed, SDX Energy

SmallCap Round Up: Physiomics, Ergomed, SDX Energy

It was an uneventful start to the week with no direction from across the Atlantic given the market holiday. The AIM index spent the majority of the session in the black before slipping the last half hour of trade to close down just over one point at 740.39.

  • Physiomics +43%
  • Ergomed +28%
  • SDX Energy +23%
  • 600 Group -49%
  • Pathfinder -29%

Physiomics LON:PYC added 43% on the day to top the board. The company announced the appointment of a new COO this morning, joining from NASDAQ listed Syneos Health, extending the run of gains from late last week in response to contract awards. The stock now sits around three month highs

Ergomed LON:ERGO was in second place, up 28% after management recommended a cash offer for the business from a private equity play. Shares have jumped to almost exactly the bid level of 1350p per share.

SDX Energy LON:SDX added 23% on the day, grabbing the notable mention. This morning the company advised that it had spudded a well in Morocco and that the site can be brought into production immediately. Further announcements will follow.


600 Group LON:SIXH was left propping up the board, having slipped 49%. The company provided an update after the close on Friday, noting critically that the report filing deadline of 30th September was likely to be missed, resulting in a temporary suspension of the stock. In addition, difficult trading conditions mean management expect the company to remain loss making.

Pathfinder LON:PFP slipped 29%, reversing some of the gains posted in late August. There’s no clear news here although a corporate action relating to an ongoing damages claim is being processed and could be impacting the underlying price.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top